IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
A Trial of Tocilizumab in ALS Subjects (TCZALS-001)
This study is currently recruiting participants.
Verified December 2016 by Shafeeq Ladha, MD, Barrow Neurological Institute
Sponsor:
Barrow Neurological Institute
Collaborators:
ALS Association
Barrow Neurological Foundation
Massachusetts General Hospital
Genentech, Inc.
Information provided by (Responsible Party):
Shafeeq Ladha, MD, Barrow Neurological Institute
ClinicalTrials.gov Identifier:
NCT02469896
First received: June 3, 2015
Last updated: December 22, 2016
Last verified: December 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2017 |
| Estimated Primary Completion Date: | June 2017 (Final data collection date for primary outcome measure) |